Nano-strategies as Oral Drug Delivery Platforms for Treatment of Cancer: Challenges and Future Perspectives

AAPS PharmSciTech. 2022 May 23;23(5):152. doi: 10.1208/s12249-022-02301-0.

Abstract

Oral drug administration is the oldest and widely used method for drug administration. The objectives behind developing an oral drug delivery for the treatment of cancer are to achieve low cost treatment by utilizing novel techniques to target cancer through gut-associated lymphoid tissue (GALT) and to enhance patient comfort and compliance through a hospital-free treatment leading to "Chemotherapy at Home." Unfortunately, due to the physiological environment of the GIT and physicochemical properties of drug candidate, the efficacy of oral drug delivery methods is limited in the treatment of cancer. Due to their low hydrophilicity, high P-gp efflux and restricted intestinal permeability most of the anti-cancer drugs fail to achieve oral bioavailability. The review focuses on the efforts, challenges, opportunities and studies conducted by scientists worldwide on the oral administration of anticancer medications via nanocarriers such as liposomes, SLNs and dendrimers, because of their potential to overcome the epithelial barrier associated with GALT, as well as the applications of different polymers in targeting the cancer. The oral delivery can set newer horizons in cancer therapy to make it more patient friendly.

Keywords: cancer; drug delivery; nanocarriers; nanotechnology; oral; polymers.

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents*
  • Biological Availability
  • Drug Carriers / chemistry
  • Drug Delivery Systems / methods
  • Humans
  • Liposomes / therapeutic use
  • Nanoparticles* / chemistry
  • Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Liposomes